NantKwest to Present at Upcoming Investment and Healthcare Conferences

CULVER CITY, Calif.--(BUSINESS WIRE)-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell-based therapeutics company, today announced that the company will be presenting and conducting one-on-one meetings at a number of investment and healthcare conferences in the month of March and April 2018. The presentations and one-on-one discussions will feature a science and business overview, along with a clinical update provided by company management.

Conference Details:

Event:                 Roth Capital 30th Annual Investment Conference
Date/Time:                 Tuesday, March 13, 2018, one-on-one meetings
Location:                 Laguna Niguel, CA
Event:                 Cowen & Company 38th Annual Healthcare Conference
Date/Time:                 Wednesday, March 14, 2018, one-on-one meetings
Location:                 Boston, MA
Event:                 Oppenheimer & Company 28th Annual Healthcare Conference
Date/Time:                 Tuesday, March 20, 2018, one-on-one meetings
Location:                 New York, NY
Event:                 Needham & Company 17th Annual Healthcare Conference
Date/Time:                 Wednesday, March 28, 2018, presentation at 12:45pm
Location:                 New York, NY
Event:                 Hanson Wade Innate Killer Summit
Date/Time:                 Thursday, March 29, 2018, presentation at 12:50pm
Location:                 New York, NY
Event:                 Jefferies IO Cell Therapy Investment Conference
Date/Time:                 Tuesday, April 3, 2018, presentation at 11:40am
Location:                 Boston, MA


Back to news